Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice

Neuroscience

Volumn 169, Issue 1, 2010, Pages 488-494

  Masliah, E ^a   Xie, F ^a   Dayan, S ^a   Rockenstein, E ^a   Mante, M ^a   Adame, A ^a   Patrick, C M ^a   Chan, A F ^a   Zheng, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid deposition; Central nervous system; Myelin derived axon growth inhibitors; Neuritic sprouting; Reticulon

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT PROTEIN; NEUROMODULIN; PROTEIN NOGO; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE DELETION; LEARNING DISORDER; MAZE TEST; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CROSSES, GENETIC; DENTATE GYRUS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FRONTAL LOBE; GLIOSIS; HUMANS; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELIN PROTEINS; NERVE TISSUE PROTEINS; NEURITES; PLAQUE, AMYLOID; POINT MUTATION; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY;

EID: 77953810696     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.04.045     Document Type: Article

References (27)

1. Buffo A., Zagrebelsky M., Huber A.B., Skerra A., Schwab M.E., Strata P., Rossi F. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons. J Neurosci 2000, 20:2275-2286.
2. Cafferty W.B., Strittmatter S.M. The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci 2006, 26:12242-12250.
3. Chana G., Landau S., Beasley C., Everall I.P., Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003, 53:1086-1098.
4. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
5. Chin J., Palop J.J., Yu G.Q., Kojima N., Masliah E., Mucke L. Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J Neurosci 2004, 24:4692-4697.
6. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001, 409:341-346.
7. Geddes J.W., Cotman C.W. Plasticity in Alzheimer's disease: too much or not enough?. Neurobiol Aging 1991, 12:330-333. discussion:352-335.
8. Gonzenbach R.R., Schwab M.E. Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo. Cell Mol Life Sci 2008, 65:161-176.
9. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000, 403:439-444.
10. Hashimoto M., Masliah E. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem Res 2003, 28:1743-1756.
11. He W., Lu Y., Qahwash I., Hu X.Y., Chang A., Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med 2004, 10:959-965.
12. Hu X., Shi Q., Zhou X., He W., Yi H., Yin X., Gearing M., Levey A., Yan R. Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO J 2007, 26:2755-2767.
13. Lee H., Raiker S.J., Venkatesh K., Geary R., Robak L.A., Zhang Y., Yeh H.H., Shrager P., Giger R.J. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci 2008, 28:2753-2765.
14. Lee J.K., Chan A.F., Luu S.M., Zhu Y., Ho C., Tessier-Lavigne M., Zheng B. Reassessment of corticospinal tract regeneration in Nogo-deficient mice. J Neurosci 2009, 29:8649-8654.
15. Lee JK, Geoffroy CG, Chan AF, Tolentino KE, Crawford MJ, Leal MA, Kang B, Zheng B (in press) Assessing spinal axon regeneration and sprouting in Nogo, MAG and OMgp deficient mice. Neuron, in press.
16. Lee J.K., Zheng B. Axon regeneration after spinal cord injury: insight from genetically modified mouse models. Restor Neurol Neurosci 2008, 26:175-182.
17. Masliah E., Mallory M., Hansen L., Alford M., DeTeresa R., Terry R., Baudier J., Saitoh T. Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease. Brain Res 1992, 574:312-316.
18. McGee A.W., Yang Y., Fischer Q.S., Daw N.W., Strittmatter S.M. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005, 309:2222-2226.
19. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000, 20:4050-4058.
20. Murayama K.S., Kametani F., Saito S., Kume H., Akiyama H., Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur J Neurosci 2006, 24:1237-1244.
21. Park J.H., Gimbel D.A., GrandPre T., Lee J.K., Kim J.E., Li W., Lee D.H., Strittmatter S.M. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci 2006, 26:1386-1395.
22. Raineteau O., Fouad K., Noth P., Thallmair M., Schwab M.E. Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. Proc Natl Acad Sci U S A 2001, 98:6929-6934.
23. Rockenstein E., Torrance M., Mante M., Adame A., Paulino A., Rose J.B., Crews L., Moessler H., Masliah E. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J Neurosci Res 2006, 83:1252-1261.
24. Selkoe D.J. Defining molecular targets to prevent Alzheimer disease. Arch Neurol 2005, 62:192-195.
25. Shi Q., Prior M., He W., Tang X., Hu X., Yan R. Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites. J Neurosci 2009, 29:9163-9173.
26. Troy C.M., Stefanis L., Greene L.A., Shelanski M.L. Mechanisms of neuronal degeneration: a final common pathway?. Adv Neurol 1997, 72:103-111.
27. Zheng B., Ho C., Li S., Keirstead H., Steward O., Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003, 38:213-224.